Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02.-Reference-Cited by-同舟云学术

Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:9027-9027
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Agarwala Sanjiv S.¹,Thompson John F²,Smithers B Mark³,Ross Merrick I.⁴,Scoggins Charles Raben⁵,Coventry Brendon J⁶,Neuhaus Susan J⁷,Minor David R.⁸,Singer Jamie M⁹,Wachter Eric Andrew⁹

Affiliation:

1. St. Luke's Hospital and Health Network, Easton, PA

2. Melanoma Institute Australia, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia

3. Princess Alexandra Hospital, Brisbane, Australia

4. The University of Texas MD Anderson Cancer Center, Houston, TX

5. University of Louisville, Louisville, KY

6. Royal Adelaide Hospital, Adelaide, Australia

7. University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia

8. California Pacific Medical Center Research Institute, San Francisco, CA

9. Provectus Biopharmaceuticals, Inc., Knoxville, TN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.9027

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019;Journal of Translational Medicine;2020-04-16

2. A nanosystem loaded with perfluorohexane and rose bengal coupled upconversion nanoparticles for multimodal imaging and synergetic chemo-photodynamic therapy of cancer;Biomaterials Science;2020

3. Management of Locally and Regionally Recurrent Melanoma;Melanoma;2019

4. Management of Locally and Regionally Recurrent Melanoma;Melanoma;2018

5. Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors;Cancer Immunology, Immunotherapy;2017-02-25